Previous Article | Next Article ![]()
Journal of Clinical Microbiology, Dec 1997, 3225-3231, Vol 35, No. 12
PF Riska, WR Jacobs Jr, BR Bloom, J McKitrick and J Chan
We have previously described a luciferase reporter mycobacteriophage (LRP)
assay that can detect Mycobacterium tuberculosis and characterize
mycobacterial drug susceptibility patterns within 24 to 48 h in positive
cultures. One drawback of this LRP protocol is the ability of the
recombinant mycobacteriophage phAE40 to infect a variety of Mycobacterium
species, thus limiting its specificity for the detection of M.
tuberculosis. In this study, we have (i) explored the host range of phAE40,
(ii) developed a modified LRP assay that exploits the selective inhibitory
effect of the compound p-nitro-alpha-acetylamino- beta-hydroxy
propiophenone (NAP) against members of the M. tuberculosis complex to
differentiate between the tubercle bacillus and other mycobacterial
species, and (iii) tested over 300 samples, including primary clinical
isolates and drug-resistant strains of M. tuberculosis, demonstrating the
ability of the NAP-modified LRP assay to identify M. tuberculosis complex
organisms with high degrees of sensitivity and specificity.
Copyright © 1997 by the American Society for Microbiology. All rights reserved.
Specific identification of Mycobacterium tuberculosis with the luciferase reporter mycobacteriophage: use of p-nitro-alpha-acetylamino- beta-hydroxy propiophenone [In Process Citation]
Division of Infectious Diseases, Montefiore Medical Center of the Albert Einstein College of Medicine, Bronx, New York 10461, USA. riska@aecom.yu.edu
This article has been cited by other articles:
| Antimicrob. Agents Chemother. | Clin. Microbiol. Rev. |
|---|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|